Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Palonosetron HCl Buccal Film Versus IV Palonosetron for Prevention of Chemotherapy-induced Nausea and Vomiting in Cancer Patients Receiving Moderately Emetogenic Chemotherapy

NCT05199818 is registered in ClinicalTrials.gov with Xiamen LP Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT05199818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05199818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Palonosetron HCl Buccal Film Versus IV Palonosetron for Prevention of Chemotherapy-induced Nausea and Vomiting in Cancer Patients Receiving Moderately Emetogenic Chemotherapy
Lead sponsor
Xiamen LP Pharmaceutical Co., Ltd
Phase
Phase 3
Overall status
Unknown status
Start date
March 1, 2022
Completion date
November 30, 2023
Enrollment
328 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced nausea and vomiting